Answers are grounded in this paper and cite their sources.
Intraoperative molecular imaging (IMI) enables the detection and visualization of cancer tissue using targeted radioactive or fluorescent tracers. While IMI research has rapidly expanded, including the recent Food and Drug Administration approval of a targeted fluorophore, the limits of detection have not been well-defined.
No takes yet. Share an insight, caveat, or question.
Sever et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: